Panagora Asset Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.28M | Buy |
28,872
+25,692
| +808% | +$2.18M | 0.01% | 608 |
|
|
2026
Q1 | $274K | Buy |
3,180
+17
| +0.5% | +$1.53K | ﹤0.01% | 1007 |
|
|
2025
Q4 | $276K | Buy |
+3,163
| New | +$240K | ﹤0.01% | 1023 |
|
|
2025
Q2 | – | Sell |
-3,371
| Closed | -$247K | – | 1149 |
|
|
2025
Q1 | $247K | Hold |
3,371
| – | – | ﹤0.01% | 987 |
|
|
2024
Q4 | $279K | Sell |
3,371
-25
| -0.7% | -$1.97K | ﹤0.01% | 978 |
|
|
2024
Q3 | $243K | Sell |
3,396
-107
| -3% | -$7.55K | ﹤0.01% | 1099 |
|
|
2024
Q2 | $240K | Buy |
+3,503
| New | +$209K | ﹤0.01% | 1096 |
|
|
2022
Q2 | – | Sell |
-300,033
| Closed | -$22.1M | – | 1522 |
|
|
2022
Q1 | $22.1M | Sell |
300,033
-2,142
| -0.7% | -$149K | 0.12% | 176 |
|
|
2021
Q4 | $21.8M | Buy |
+302,175
| New | +$21.9M | 0.12% | 174 |
|
|
2021
Q3 | – | Sell |
-2,115
| Closed | -$164K | – | 1985 |
|
|
2021
Q2 | $164K | Sell |
2,115
-99
| -4% | -$7.04K | ﹤0.01% | 1712 |
|
|
2021
Q1 | $137K | Buy |
2,214
+1,768
| +396% | +$112K | ﹤0.01% | 1830 |
|
|
2020
Q4 | $29K | Sell |
446
-135
| -23% | -$7.76K | ﹤0.01% | 2131 |
|
|
2020
Q3 | $29K | Sell |
581
-5,110
| -90% | -$264K | ﹤0.01% | 2124 |
|
|
2020
Q2 | $272K | Sell |
5,691
-147,092
| -96% | -$7.1M | ﹤0.01% | 1417 |
|
|
2020
Q1 | $6.5M | Sell |
152,783
-80,515
| -35% | -$3.98M | 0.05% | 300 |
|
|
2019
Q4 | $13.7M | Buy |
233,298
+224,002
| +2,410% | +$12.2M | 0.06% | 281 |
|
|
2019
Q3 | $475K | Sell |
9,296
-140,141
| -94% | -$6.67M | ﹤0.01% | 1305 |
|
|
2019
Q2 | $6.32M | Buy |
149,437
+41,838
| +39% | +$1.82M | 0.03% | 439 |
|
|
2019
Q1 | $5.32M | Buy |
107,599
+13,912
| +15% | +$629K | 0.02% | 495 |
|
|
2018
Q4 | $4.05M | Buy |
93,687
+602
| +0.6% | +$30K | 0.02% | 524 |
|
|
2018
Q3 | $5.28M | Buy |
93,085
+29,721
| +47% | +$1.56M | 0.02% | 507 |
|
|
2018
Q2 | $3.2M | Buy |
63,364
+35,472
| +127% | +$1.85M | 0.01% | 698 |
|
|
2018
Q1 | $1.39M | Buy |
27,892
+27,775
| +23,739% | +$1.31M | 0.01% | 1030 |
|
|
2017
Q4 | $5K | Buy |
+117
| New | +$4.1K | ﹤0.01% | 2253 |
|
|
2017
Q3 | – | Sell |
-913
| Closed | -$30K | – | 2386 |
|
|
2017
Q2 | $30K | Buy |
+913
| New | +$28.7K | ﹤0.01% | 2176 |
|
|
2016
Q1 | – | Sell |
-1,147
| Closed | -$32K | – | 2310 |
|
|
2015
Q4 | $32K | Sell |
1,147
-1,613
| -58% | -$40.5K | ﹤0.01% | 2083 |
|
|
2015
Q3 | $57K | Sell |
2,760
-2,584
| -48% | -$65.4K | ﹤0.01% | 1961 |
|
|
2015
Q2 | $137K | Sell |
5,344
-2,799
| -34% | -$70.9K | ﹤0.01% | 1845 |
|
|
2015
Q1 | $206K | Buy |
+8,143
| New | +$198K | ﹤0.01% | 1658 |
|
Other funds holding GMED
JT
SC
Panagora Asset Management's GMED Position: Q2 2026 in Review
Panagora Asset Management increased its Globus Medical (GMED) stake by 808% in Q2 2026, buying an estimated $2.18M and bringing the position to 28,872 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #608.
Panagora Asset Management first reported a position in GMED in Q1 2015 and has held it in 29 quarters since. The position peaked at $22.1M in Q1 2022. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Panagora Asset Management held 28,872 shares of Globus Medical worth $2.28M as of Q2 2026.
- Panagora Asset Management bought 25,692 Globus Medical shares in Q2 2026, an estimated $2.18M.
- Globus Medical made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #608 holding.
- Panagora Asset Management first reported a position in Globus Medical in Q1 2015 and has held it in 29 quarters since.
- Panagora Asset Management's Globus Medical position peaked at $22.1M in Q1 2022.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.